Harvard Internal Medicine Comprehensive Review and Update 2021

Harvard Internal Medicine Comprehensive Review and Update 2021

By Harvard Medical School 2021

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

Comprehensive Updates, Strategies and Practice Recommendations for State-of-the-Art Internal Medicine

Internal Medicine Comprehensive Review and Update 2021 will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. 

Overview

This program, the 61st Annual Internal Medicine Update from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital, provides comprehensive instruction to ensure clinicians are current with the latest evidence and best practices to optimize patient care.

This program covers the breadth of Internal Medicine subspecialties, including:

• Cardiovascular Medicine
• Pulmonary Medicine
• Critical Care
• Hematology and Oncology
• Mind-Body Medicine
• Infectious Diseases
• Gastroenterology
• Endocrinology
• Rheumatology
• Nephrology
• Allergy and Immunology
• Geriatrics

• Immunotherapies and Biologics
• Lifestyle Medicine
• Women’s Health
• Obesity Medicine
• Hospital Medicine
• Addiction Medicine
• Neurology
• Psychiatry
• Palliative Care
• Dermatology
• Pain Medicine

Practical, Results-Focused Education for Ambulatory and Inpatient Settings

Enhance your skills and optimize your patient outcomes by joining Harvard Medical School’s most distinguished faculty—across all relevant fields of Internal Medicine—as they provide updates, best practices and clinical strategies designed to improve day-to-day practice in both ambulatory and inpatient settings.

►Now in its 61st year, this program is among the highest-rated Harvard Medical School CME courses.

Program Highlights:

Highlights of the 2021 program, comprising 80+ high-impact, incisive educational sessions, include:

• Comprehensive updates across all areas of Internal Medicine presented by Harvard Medical School’s leading clinical faculty and most distinguished teachers
• Specific evidence-based recommendations to incorporate updates into practice for optimized patient care and outcomes
• Outcomes-driven strategies to improve diagnosis and management of diseases seen in both ambulatory and inpatient settings
• Case-based sessions and daily Q&A sessions with Harvard faculty
• Expanded treatment options for:
  • Cardiovascular disease (including CVD in women)
  • Obesity (including medical and surgical management)
  • Diabetes and novel therapeutic strategies
  • Women’s health
  • COPD, asthma and obstructive sleep apnea
  • Smoking cessation and alcohol use disorders
  • IBD, functional bowel disorders, eosinophilic syndromes and upper tract diseases
  • Vasculitis, SLE, rheumatoid arthritis, and more
• The state of the art in:
  • Coronary artery disease screening
  • Acute coronary syndrome management
  • Anticoagulation strategies
  • Delirium and its management
  • Thromboembolic disease and its complications
  • Immunotherapies and biologics
  • Cancer screening strategies
  • Mind-Body Medicine and the evidence behind it
  • Emerging infections and clinical management of pneumonia
  • HIV medicine, care of the immunosuppressed host, and skin/soft tissue infections
  • Telemedicine advances and challenges
  • Management of C. difficile (including new therapies)
  • Immunization strategies
  • Diagnostic and treatment strategies for viral hepatitis
  • Addiction medicine, including safe opioid prescription
  • Acute kidney injury, acid-base disorders and care of patients with chronic kidney disease
  • Contemporary care of the LGBTQ patient
  • Osteoporosis management and approach to the patient with menopausal symptoms
  • Diagnosis and management of anxiety and depression
• The latest guidelines for:
  • Breast cancer and GYN cancer screening
  • Additional cancer screening (including prostate and colon)
  • Hyperlipidemia and hypertension
  • Diagnosis and management of sepsis
  • Rational antibiotic use in the era of rising antimicrobial resistance
• A live, interactive New England Journal of Medicine (NEJM)  Clinicopathologic Conference (CPC) session